Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl… Read more
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.007x
Based on the latest financial reports, Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a cash flow conversion efficiency ratio of 0.007x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹8.20 Million) by net assets (₹1.19 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aarey Drugs & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Aarey Drugs & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aarey Drugs & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aarey Drugs & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mint S.A.
LSE:0W8Y
|
N/A |
|
Aztec Land Comb Cert
PINK:AZLCZ
|
N/A |
|
iOThree Limited Ordinary Shares
NASDAQ:IOTR
|
N/A |
|
Equus Energy Ltd
AU:EQU
|
-0.061x |
|
Big Ridge Gold Corp
OTCQB:ALVLF
|
-0.023x |
|
SURGEPAYS INC. DL-001
F:9B90
|
N/A |
|
LITIUM AB SK1
F:5TW
|
N/A |
|
GFM Services Bhd
KLSE:0039
|
0.033x |
Annual Cash Flow Conversion Efficiency for Aarey Drugs & Pharmaceuticals Limited (2009–2025)
The table below shows the annual cash flow conversion efficiency of Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹1.38 Billion | ₹8.95 Million | 0.006x | +128.66% |
| 2024-03-31 | ₹1.33 Billion | ₹-29.94 Million | -0.023x | -106.66% |
| 2023-03-31 | ₹1.17 Billion | ₹-12.81 Million | -0.011x | +72.40% |
| 2022-03-31 | ₹1.14 Billion | ₹-44.93 Million | -0.040x | -171.37% |
| 2021-03-31 | ₹988.60 Million | ₹54.77 Million | 0.055x | +79.06% |
| 2020-03-31 | ₹923.46 Million | ₹28.57 Million | 0.031x | +288.83% |
| 2019-03-31 | ₹865.53 Million | ₹6.89 Million | 0.008x | +103.14% |
| 2018-03-31 | ₹802.45 Million | ₹-203.51 Million | -0.254x | -1427.42% |
| 2017-03-31 | ₹503.60 Million | ₹9.62 Million | 0.019x | -87.61% |
| 2016-03-31 | ₹366.97 Million | ₹56.59 Million | 0.154x | +67.84% |
| 2015-03-31 | ₹354.09 Million | ₹32.53 Million | 0.092x | +851.96% |
| 2014-03-31 | ₹345.21 Million | ₹-4.22 Million | -0.012x | -112.13% |
| 2013-03-31 | ₹334.70 Million | ₹33.72 Million | 0.101x | +136.83% |
| 2012-03-31 | ₹328.12 Million | ₹-89.76 Million | -0.274x | +39.84% |
| 2011-03-31 | ₹219.05 Million | ₹-99.61 Million | -0.455x | -254.49% |
| 2010-03-31 | ₹92.08 Million | ₹-11.81 Million | -0.128x | -3666.00% |
| 2009-03-31 | ₹83.97 Million | ₹302.06K | 0.004x | -- |